Superworth

Medicinova EPS MNOV

Diluted earnings per share by quarter and over the last twelve months, from 2010.

Last 12 months, to Jun 30, 2026
−$0.22
Latest quarter, Q2 FY26
−$0.05
Fiscal year 2025
−$0.25

Medicinova's earnings per share was −$0.22 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.05.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.25n/a
FY2024−$0.23n/a
FY2023−$0.17n/a
FY2022−$0.28n/a
FY2021−$0.20n/a
FY2020−$0.31n/a
FY2019−$0.30n/a
FY2018−$0.36n/a
FY2017−$0.32n/a
FY2016−$0.33n/a
FY2015−$0.33n/a
FY2014−$0.39n/a
FY2013−$0.23n/a
FY2012−$0.66n/a
FY2011−$1.23n/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.05n/a−$0.22
Q1 FY26−$0.05n/a−$0.24
Q4 FY25−$0.06n/a−$0.25
Q3 FY25−$0.06n/a−$0.25
Q2 FY25−$0.07n/a−$0.25
Q1 FY25−$0.06n/a−$0.23
Q4 FY24−$0.06n/a−$0.23
Q3 FY24−$0.06n/a−$0.21
Q2 FY24−$0.05n/a−$0.16
Q1 FY24−$0.06n/a−$0.17
Q4 FY23−$0.04n/a−$0.17
Q3 FY23−$0.01n/a−$0.19

Against its peers

Companies in Drug Manufacturers - General nearest Medicinova's size, closest first, today.

CompanyEPS, 12 monthsGrowth
MNOVMedicinova−$0.22
SPROSpero Therapeutics$0.11
LFVNLifevantage$0.40−46% a year
ATNMActinium Pharmaceuticals$0.36
NATRNatures Sunshine Products$1.01+36% a year
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
Peer median$0.52

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Medicinova

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.